Introduction
Voltage-gated sodium channels (Na V ) regulate neuronal excitability by initiation and propagation of action potentials and amplification of subthreshold synaptic events. Four pore-forming Na V α subunits are primarily expressed in adult mammalian brain: Na V 1.1, Na V 1.2, Na V 1.3, and Na V 1.6, encoded by the SCN1A, SCN2A, SCN3A, and SCN8A genes, respectively. Mutations in SCN1A are the leading cause for a wide range of genetic epilepsies (Harkin et al., 2007) , all involving infantile onset of febrile seizures that proceed beyond childhood. Missense mutations in SCN1A commonly lead to Genetic Epilepsy with Febrile Seizures Plus (GEFS+), a mild dominantly inherited epilepsy, with febrile and afebrile seizures that are well controlled by anti-epileptic drugs (Gambardella and Marini, 2009; Scheffer et al., 2009) . Truncation mutations and other severe loss-of-function mutations cause Dravet Syndrome (DS, also called Severe Myoclonic Epilepsy of Infancy), a rare, genetically dominant, intractable convulsive disorder that begins during the first year of life, with seizures often associated with fever, and progresses to prolonged refractory seizures and frequent episodes of status epilepticus. During and after the second year of life, patients develop psychomotor delay, ataxia, cognitive impairment, and social interaction deficits (Genton et al., 2011; Li et al., 2011) . Eighty percent of the identified mutations in DS arise de novo; however, ten to twenty percent of DS cases are inherited from mildly affected or unaffected parents (Claes et al., 2001 (Claes et al., , 2003 Depienne et al., 2010; Suls et al., 2010) . Individual patients with apparently complete loss-of-function mutations demonstrate a broad range of disease severity and a wideranging combination of symptoms, suggesting that genetic background can strongly influence the severity and clinical presentation of DS (Dravet et al., 2005) .
Mouse models of DS (Na V 1.1 +/− ) (Ogiwara et al., 2007; Yu et al., 2006) demonstrated striking similarities to the human disease, with temperature-and age-dependent onset, and progression to myoclonic and generalized tonic-clonic seizures (Oakley et al., 2009) . Genetic background can vastly affect seizure severity in mouse models and human patients (Frankel, 2009; Schauwecker, 2011 
